STK33 Products

Antibodies
Antibody Pairs
STK33 Antibody Pair
STK33 Antibody Pair
H00065975-AP11
Species: Hu
Applications: S-ELISA
STK33 Antibody Pair
STK33 Antibody Pair
H00065975-PW4
Species: Hu
Applications: WB, IP
STK33 Antibody Pair
STK33 Antibody Pair
H00065975-PW1
Species: Hu
Applications: WB, IP
Lysates
STK33 Overexpression Lysate
STK33 Overexpression Lysate
NBL1-16551
Species: Hu
Applications: WB
Proteins
Recombinant Human STK33 Prote ...
Recombinant Human STK33 Protein
H00065975-P01
Species: Hu
Applications: WB, ELISA, PA, AP, KA
STK33 Recombinant Protein Ant ...
STK33 Recombinant Protein Antigen
NBP2-58674PEP
Species: Hu
Applications: AC
STK33 Recombinant Protein Ant ...
STK33 Recombinant Protein Antigen
NBP1-86069PEP
Species: Hu
Applications: AC

Description

Serine/threonine Kinase 33 (STK33) is expressed at high levels in testis and the fetal lung and heart, and at lower levels in a number of other tissues. However, STK33 is different form the other serine/threonine kinases in that it is not expressed in neural tissues. STK33 is thought to be involved in the phosphorylation of vimentin. Additionally, STK33 has been identified as a synthetic lethal in KRAS mutant lung cancers.

Bioinformatics

Entrez Human
Mouse
Uniprot Human
Human
Human
Human
Mouse
Product By Gene ID 65975
Alternate Names
  • EC 2.7.11
  • EC 2.7.11.1
  • serine/threonine-protein kinase 33
  • serine/threonine kinase 33

Pathways for STK33

View related products by pathway and learn more about each of the pathways below.

Rna Interference
Cell Adhesion
Translation
Cell Cycle
Localization
Spermatogenesis

Research Areas for STK33

Find related products by research area and learn more about each of the different research areas below.

Cancer
Protein Kinase

PTMs for STK33

Learn more about PTMs related to STK33.

Phosphorylation

Bioinformatics Tool for STK33

Discover related pathways, diseases and genes to STK33. Need help? Read the Bioinformatics Tool Guide for instructions on using this tool.
 
Vizit™, under license from BioVista Inc.